| TAK-935 Multiple Rising Dose Study in Healthy Participants (NCT02539134) | Takeda | 2015-09-01 |
| Study of Intravenous RXDX-107 in Patients With Solid Tumors (NCT02548390) | Hoffmann-La Roche | 2015-09-01 |
| Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus (NCT02536859) | Novo Nordisk A/S | 2015-08-31 |
| MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors (NCT02517398) | EMD Serono Research & Development Institute, Inc. | 2015-08-31 |
| Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REL-1017 (d-Methadone) (NCT03638869) | Relmada Therapeutics, Inc. | 2015-08-31 |
| A Study of AL-794 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses, and the Antiviral Activity of Multiple Doses in an Influenza Challenge Study (NCT02588521) | Alios Biopharma Inc. | 2015-08-31 |
| Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma (NCT02352831) | Washington University School of Medicine | 2015-08-31 |
| Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma (NCT02356458) | Swiss Cancer Institute | 2015-08-31 |
| A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults. (NCT02547974) | GlaxoSmithKline | 2015-08-31 |
| Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure (NCT02546583) | Yale University | 2015-08-31 |
| A Phase 1 Study of AMG 330 in Subjects With Myeloid Malignancies (NCT02520427) | Amgen | 2015-08-31 |
| A Study of AK0529 in Infants Hospitalized With RSV (NCT02460016) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2015-08-28 |
| Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participants With Metastatic Triple-Negative Breast Cancer (mTNBC) (NCT02513472) | Eisai Inc. | 2015-08-28 |
| Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus (NCT02535689) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2015-08-28 |
| Autologous Polyclonal Tregs for Lupus (NCT02428309) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-08-27 |
| A Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding/Pharmacodynamics in Healthy Participants (NCT02561923) | Janssen Scientific Affairs, LLC | 2015-08-27 |
| Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors (NCT02319018) | National Cancer Institute (NCI) | 2015-08-27 |
| Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM (NCT02555007) | Assistance Publique Hopitaux De Marseille | 2015-08-26 |
| Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC) (NCT02437136) | Syndax Pharmaceuticals | 2015-08-26 |
| Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients. (NCT02315768) | University of California, San Diego | 2015-08-26 |
| Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma (NCT02495103) | National Cancer Institute (NCI) | 2015-08-26 |
| TAK-653 Escalating Single and Multiple Dose Study in Healthy Participants (NCT02561156) | Neurocrine Biosciences | 2015-08-26 |
| Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART) (NCT02411539) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-08-25 |
| Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma (NCT02590263) | AbbVie | 2015-08-24 |
| A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF (NCT02411786) | University of Wisconsin, Madison | 2015-08-24 |
| Phase I, Study in Chinese NSCLC Patients (NCT02529995) | AstraZeneca | 2015-08-24 |
| Safety, Tolerability and Pharmacokinetics of Single Doses of TS-134 in Healthy Volunteers (NCT03746067) | Taisho Pharmaceutical R&D Inc. | 2015-08-21 |
| Wild-Type Reovirus, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT02514382) | University of Southern California | 2015-08-21 |
| NMP in Relapsed / Refractory Myeloma (NCT02468687) | Peter MacCallum Cancer Centre, Australia | 2015-08-20 |
| Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous (NCT02320357) | University Hospital, Bordeaux | 2015-08-19 |
| Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting Conditions (NCT02658422) | GlaxoSmithKline | 2015-08-18 |
| Study to Evaluate the Pharmacokinetics of Selonsertib in Participants With Normal and Impaired Hepatic Function (NCT02509624) | Gilead Sciences | 2015-08-18 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MHAB5553A in Healthy Volunteers (NCT02528903) | Genentech, Inc. | 2015-08-18 |
| Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia (NCT02381548) | National Cancer Institute (NCI) | 2015-08-18 |
| Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection (NCT02527460) | National Institute of Neurological Disorders and Stroke (NINDS) | 2015-08-17 |
| Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus (NCT02500979) | AstraZeneca | 2015-08-17 |
| Optimising DNA Vaccinations in Healthy Volunteers (NCT03663998) | Imperial College London | 2015-08-15 |
| A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on Pharmacokinetics (NCT02547870) | Janssen Infectious Diseases BVBA | 2015-08-14 |
| Phase I Dose Escalation Study of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks in Japanese Subjects With Advanced Malignancies (NCT02485119) | Bayer | 2015-08-14 |
| Study to Evaluatethe Bioavailability and Food Effect Lenalidomide as an Oral Suspension (NCT02521714) | Celgene | 2015-08-14 |
| Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC) (NCT02447887) | Fox Chase Cancer Center | 2015-08-14 |
| Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer (NCT02522715) | OHSU Knight Cancer Institute | 2015-08-13 |
| Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study Extension (NCT02531217) | aTyr Pharma, Inc. | 2015-08-13 |
| Bioavailability Study of Vemurafenib in Participants With BRAF^V600 Mutation-Positive Malignancies (NCT02441465) | Hoffmann-La Roche | 2015-08-13 |
| A Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic Function (NCT02524717) | Aragon Pharmaceuticals, Inc. | 2015-08-13 |
| A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques (NCT02350426) | GlaxoSmithKline | 2015-08-12 |
| Sirolimus for the Treatment of Hyperinsulinism (NCT02524639) | Children's Hospital of Philadelphia | 2015-08-12 |
| Safety and Pharmacokinetics of BPI-9016M in Patients With Advanced Solid Tumors (NCT02478866) | Betta Pharmaceuticals Co., Ltd. | 2015-08-11 |
| Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation (NCT02492737) | Agios Pharmaceuticals, Inc. | 2015-08-07 |
| Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant (NCT02526329) | Everett Meyer | 2015-08-06 |
| AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors (NCT02511795) | AstraZeneca | 2015-08-06 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 443139 in Participants With Early Manifest Huntington's Disease (NCT02519036) | Ionis Pharmaceuticals, Inc. | 2015-08-06 |
| Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck (NCT02499328) | AstraZeneca | 2015-08-06 |
| Phase 1 Study(Additional) of URC102 in Healthy Subjects (NCT02524678) | JW Pharmaceutical | 2015-08-05 |
| Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis (NCT02510937) | Celgene | 2015-08-05 |
| MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients (NCT02560220) | Heidelberg University | 2015-08-05 |
| A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris (NCT02656485) | AOBiome LLC | 2015-08-05 |
| MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas (NCT02311582) | Washington University School of Medicine | 2015-08-05 |
| A Study of Escalating Doses of DCDS0780A in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NCT02453087) | Hoffmann-La Roche | 2015-08-04 |
| Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or Previously Untreated Chronic Lymphocytic Leukemia (NCT02427451) | Kerry Rogers | 2015-08-03 |
| Bioavailability of BMS-626529 in Healthy Subjects From Prototype Low Dose Extended Release Formulations (Part 1) and Prototype Extended Release Multi-particulate Formulations (Part 2) of BMS-663068 Relative to 600 mg Extended Release Tablet (NCT02508064) | ViiV Healthcare | 2015-08-03 |
| Study of the AFB and Stenting of the Iliac Arteries (NCT02209350) | Meshalkin Research Institute of Pathology of Circulation | 2015-08-02 |
| The Effects of Ondansetron on Brain Function (NCT02460341) | Icahn School of Medicine at Mount Sinai | 2015-08-01 |
| Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation (NCT02538367) | Yuhan Corporation | 2015-08-01 |
| A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel (NCT04035473) | Athenex, Inc. | 2015-08-01 |
| Obeticholic Acid in Morbidly Obese Patients and Healthy Volunteers (NCT02532335) | Sahlgrenska University Hospital | 2015-08-01 |
| Safety, Tolerability and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Healthy Asian and Caucasian Male Volunteers (NCT02596217) | AbbVie | 2015-08-01 |
| Fluorescence Spectroscopy Guided Surgery (NCT02473380) | Hospices Civils de Lyon | 2015-08-01 |
| A First in Human Study of RT001 in Patients With Friedreich's Ataxia (NCT02445794) | Biojiva LLC | 2015-08-01 |
| A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Single Doses of Q203 in Normal, Healthy, Male and Female Volunteers (NCT02530710) | Qurient Co., Ltd. | 2015-08-01 |
| HEMOBLAST Pilot Clinical Investigation (NCT02502019) | Biom'Up France SAS | 2015-08-01 |
| Reinforcing Effects of Cocaine During Phendimetrazine Maintenance (NCT02522325) | William Stoops | 2015-08-01 |
| Effects of Berry Peel Intake on Glucose Metabolism in Healthy Subjects (NCT02533986) | Lund University | 2015-08-01 |
| Study of Topical Ocular PAN-90806 in PDR (NCT02475109) | PanOptica, Inc. | 2015-08-01 |
| Efficacy of Tranexamic Acid In Reducing Blood Loss During Cesarean Section Because Of Placenta Previa (NCT02688127) | Medical Research Council | 2015-08-01 |
| Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs (NCT02548286) | Chong Kun Dang Pharmaceutical | 2015-08-01 |
| Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581 (NCT02567370) | Amgen | 2015-08-01 |
| A Genotype Stratification Study for Pharmacokinetics and Pharmacodynamics of Amitriptyline in Healthy Male Subjects (NCT02519400) | Asan Medical Center | 2015-08-01 |
| Companion Study for Patients Who Completed Participation in a REGN2810 (Anti-PD-1) Clinical Study (NCT02520245) | Regeneron Pharmaceuticals | 2015-08-01 |
| Chidamide in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 Reservoir (NCT02513901) | Tang-Du Hospital | 2015-08-01 |
| Study to Evaluate the Pharmacodynamic Effects of a Single Oral Dose of GS-0976 (NDI-010976) in Healthy Adult Subjects (NCT02876796) | Gilead Sciences | 2015-08-01 |
| Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL (NCT02689726) | Genticel | 2015-08-01 |
| Stem Cell Therapy for Outer Retinal Degenerations (NCT02903576) | Federal University of São Paulo | 2015-08-01 |
| A Bio-equivalence Study of Sofosbuvir From Elbanovir 400 mg Film Coated Tablets ( Multi-Apex Pharma, Egypt) & Sovaldi 400 mg Film Coated Tablets (Gilead Sciences, United Kingdom) (NCT02605798) | Genuine Research Center, Egypt | 2015-08-01 |
| The Metabolite Identification and Material Balance Study of SP2086 (NCT02815748) | Jiangsu HengRui Medicine Co., Ltd. | 2015-08-01 |
| Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers (NCT02558413) | Biota Pharmaceuticals, Inc. | 2015-08-01 |
| To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus (NCT02528396) | Adocia | 2015-08-01 |
| Centella Asiatica (Gotukola) Mouthwash as an Adjunct to Mechanical Plaque Control (NCT02827305) | Sri Hasanamba Dental College and Hospital | 2015-08-01 |
| Evaluating the Bioequivalence of HIP1302, HGP1406 (NCT02545829) | Hanmi Pharmaceutical Company Limited | 2015-08-01 |
| RejuvenAir Lobectomy for Safety and Histology (NCT02483052) | CSA Medical, Inc. | 2015-08-01 |
| Pharmacokinetics of HCP1401 and Co-administration of HCP0605, HGP1405 in Healthy Male Volunteers (NCT04252872) | Hanmi Pharmaceutical Company Limited | 2015-08-01 |
| Endoscopic Full Thickness Resection Without Exposure to Peritoneum (NCT02764944) | National Cancer Center, Korea | 2015-08-01 |
| Delivery of Yamani-15/5 Chemical Solution for PAD (NCT02539303) | Mayo Clinic | 2015-08-01 |
| Effect of Food on the Bioavailability of 15 mg Estetrol/3 mg Drospirenone Tablets in Healthy Female Volunteers (NCT02852681) | Estetra | 2015-08-01 |
| Using Covered Stent of Diameter of 7mm in TIPS (NCT02541825) | Beijing Shijitan Hospital, Capital Medical University | 2015-08-01 |
| An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers (NCT03724292) | Vitae Pharmaceuticals Inc., an Allergan affiliate | 2015-08-01 |
| Escalating Single Dose Study of Epsi- Gam in Healthy Normal Subjects (NCT02559258) | Tunitas Therapeutics, Inc. | 2015-08-01 |
| Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib (NCT02538627) | Merrimack Pharmaceuticals | 2015-08-01 |
| HuMax-IL8 (Interleukin8) in Patients With Advanced Malignant Solid Tumors (NCT02536469) | Bristol-Myers Squibb | 2015-08-01 |
| Effect of Gelofusine on GLP1-receptor Imaging (NCT02541734) | Radboud University Medical Center | 2015-08-01 |